Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoproliferative Disorders × Gemcitabine × 1 year × Clear all

Sponsor

Conditions

Pancreatic Neoplasms 104 Urinary Bladder Neoplasms 48 Carcinoma, Non-Small-Cell Lung 44 Cholangiocarcinoma 29 Biliary Tract Neoplasms 29 Neoplasm Metastasis 26 Ovarian Neoplasms 23 Lymphoma, Large B-Cell, Diffuse 23 Breast Neoplasms 23 Carcinoma, Transitional Cell 20 Nasopharyngeal Carcinoma 19 Lung Neoplasms 19 Non-Muscle Invasive Bladder Neoplasms 17 Neoplasms 17 Colorectal Neoplasms 17 Recurrence 16 Triple Negative Breast Neoplasms 15 Gallbladder Neoplasms 15 Fallopian Tube Neoplasms 12 Sarcoma 10 Hodgkin Disease 10 Uterine Cervical Neoplasms 9 Parkinson Disease 4, Autosomal Dominant Lewy Body 9 Bile Duct Neoplasms 9 Lymphoma, Non-Hodgkin 8 Lymphoma 8 Stomach Neoplasms 7 Adenocarcinoma 7 Nasopharyngeal Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 5

Interventions

Cyclophosphamide 6 fludarabine 4 Rituximab 4 fludarabine phosphate 3 Vincristine 3 Tacrolimus 3 Prednisone 3 Mycophenolic Acid 3 Etoposide 3 Doxorubicin 3 Busulfan 3 venetoclax 2 Whole-Body Irradiation 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Mesna 2 Melphalan 2 Bortezomib 2 trametinib 1 pertuzumab 1 liposomal doxorubicin 1 isatuximab 1 ibrutinib 1 etoposide phosphate 1 enzalutamide 1 entrectinib 1 dabrafenib 1 cobimetinib 1 capmatinib 1 atezolizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡